RUNX2 and breast carcinoma: Recent studies utilizing breast cancer cell lines with MAPK mutations or expressing mutant RAS produced several key findings which suggest that MAPK mutation contribute to autophagy dysregulation and show a similar phenotype to that of aberrant Runx2 expression.